A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
A study to assess the Pharmacodynamics of oral AR-C165395XX after Administration of Repeated
Doses for 3 days in Subjects with Type 2 Diabetes Mellitus